000 03784ntm a2200373 i 4500
001 vtls000102948
003 KUKTEM
005 20251117113356.0
008 180212s2017 my a f am 000 0 eng d
020 _aTHE0000834(Local)
039 9 _a201905271216
_bnazirah
_y201802121020
_zsaini
040 _aUMP
_beng
_cUMP
_erda
090 _aFKKSA .A43 2017 r Bc.
100 0 _aNur Amanina Mohamad Adaris,
_eauthor.
245 1 0 _aScreening of carbamazepine-saccharin (CBC-SAC) co-crystal /
_cNur Amanina Mohamad Adaris
264 1 _aKuantan, Pahang :
_bUMP,
_c2017
264 4 _c© 2017
300 _axv, 61 pages :
_billustrations (some color) ;
_c30 cm. +
_e1 CD-ROM
336 _atext
_2rdacontent
336 _atext
_2rdacontent
337 _aunmediated
_2rdamedia
337 _acomputer
_2rdamedia
338 _avolume
_2rdacarrier
338 _acomputer disc
_2rdacarrier
347 _atext file
_bPDF
_2rda
500 _aFaculty of Chemical & Natural Resources Engineering
502 _aProject Paper (Bachelor of Chemical Engineering) -- Universiti Malaysia Pahang – 2017
504 _aIncludes bibliographical references and index
520 3 _aCo-crystallization is a method in formulation of drug products which is believed to improve drugs solubility, stability and dissolution rate while maintaining the biological functions of its chemical properties. The recent advances in this area have brought this research possible in order to produce pharmaceutical material by crystallization design of carbamazepine (CBZ) using saccharin (SAC) as its co-crystal. This research is conducted to examine formation of carbamazepine-saccharin (CBZ-SAC) co-crystal screening approaches that uses different solvent based crystallization technique in varies solvent system (ethyl acetate solvent and formic acid solvent). In this method, to prepare the co-crystal product CBZ-SAC four crystallization technique are used which are cooling crystallization, solvent crystallization, slurry and stirring in varies solvent of ethyl acetate and formic acid. Different mol ratio of CBZ and SAC are being tested, in order to study CBZ-SAC co-crystal formation. Physical characterization of the co-crystal is being characterized by x-ray powder diffraction (XPRD), differential scanning calorimetry (DSC), fourier transform infrared spectroscopic (FTIR) and optical microscopic. The XPRD analysis had confirmed that only CBZ-SAC co-crystal in ethyl acetate solvent were successfully formed while in formic acid solvent the crystal formed were only SAC. The XRPD pattern profile analysis shown that CBZ-SAC Form I and Form II was produced from different ratios and different methods and it have their own melting point based from the DSC analysis which are 170-172°C and173-177°C respectively. The morphology of the crystal are mostly plate like and needle like shape which indicate Form I and Form II respectively for the polymorphic characterisation. Since two type of polymorph were successfully produced, it is shown that solvent, methods and ratios plays an important role to CBZ-SAC co-crystal formation. Further study in screening is needed for co-crystal formation assessment since there were already many factors proven in affecting the polymorphic formation of the co-crystal such as different methods, solvent and mole ratio. Besides that varies solvent type should be implemented to investigate if the solvent yield CBZ-SAC co-crystal formation and its polymorph.
610 2 0 _aFaculty of Chemical & Natural Resources Engineering
_xDissertations
650 0 _aUniversities and Colleges
_xDissertations
650 0 _aTheses
999 _aVIRTUA40
_c7600
_d7606
999 _aVTLSSORT0080*0200*0400*0900*1000*2450*2640*2641*3000*3360*3361*3370*3371*3380*3381*3470*5000*5020*5040*5200*6100*6500*6501*9992